(5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway. - Wikidata - wikimedia - TriplyDB

(5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway.

(5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway.

http://www.wikidata.org/entity/Q35233222

about

(5R)-5-hydroxytriptolide (LLDT-8) prevents collagen-induced arthritis through OPG/RANK/RANKL signaling in a rat model of rheumatoid arthritis Circulating osteoprotegerin levels are elevated in rheumatoid arthritis: a systematic review and meta-analysis.Phylogeographic and phylogenetic analysis for Tripterygium species delimitation

P2860

Q39157409-CEF7EE1A-F0CD-4229-89DB-913CB620E3BB Q39429775-0EEBADA8-0EB8-426C-8FD0-4130DBE93315 Q42671293-600B6EC8-454F-4812-BD71-19D29C7DF78A

P2860

(5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway.

http://www.wikidata.org/entity/Q35233222

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

(5R)-5-Hydroxytriptolide (LLDT ...... KL/RANK/OPG signaling pathway.

@ast

(5R)-5-Hydroxytriptolide (LLDT ...... KL/RANK/OPG signaling pathway.

@en

type

label

(5R)-5-Hydroxytriptolide (LLDT ...... KL/RANK/OPG signaling pathway.

@ast

(5R)-5-Hydroxytriptolide (LLDT ...... KL/RANK/OPG signaling pathway.

@en

prefLabel

(5R)-5-Hydroxytriptolide (LLDT ...... KL/RANK/OPG signaling pathway.

@ast

(5R)-5-Hydroxytriptolide (LLDT ...... KL/RANK/OPG signaling pathway.

@en

P1433

Q35233222-C4AF735A-08BE-4B3F-9550-9B91272FEEB4

P1476

Q35233222-F201E5C4-B36A-4BAF-9FA5-2C9C68305E30

P2093

Q35233222-04FA8C7B-5723-4406-B735-C940AB61F731

Q35233222-2FCC257B-84C9-4FE7-ADA7-6914A0AACB46

Q35233222-56FEACE4-99D8-4852-A93F-B3B88C5A7025

Q35233222-7BA20454-D72F-4FF7-954C-E7DF462BD72D

Q35233222-95C7AEC8-7EA4-4780-A4E9-FBA71C4C36A3

Q35233222-C4995F92-1ECF-46B0-AC12-78DCCD0BC253

Q35233222-DDCED062-F8C8-4FA6-81EC-059915E62E3F

P2860

Q35233222-07656A51-385E-4C19-A959-4A3BD497C8C8

Q35233222-18A63D48-70DA-493E-849C-D697AB701DF8

Q35233222-2C8D94DC-294E-4F7F-9CC8-EF69C6A32866

Q35233222-3E685525-D5AA-4E57-B428-79ED09AC561A

Q35233222-42862C07-F893-48B5-AE7B-7DB2CF9ACA15

Q35233222-4554568B-2FBE-4B95-9975-ABC5AB0F99EB

Q35233222-6321745A-1802-4353-935D-E73D3CA2303B

Q35233222-75D99138-6150-4B4B-8636-EECD12B06CD3

Q35233222-897451F6-3DDB-40C2-9C1B-1A9ECA3E5101

Q35233222-9535CC13-CC41-43E8-B989-8CFCB6F496F0

P2888

Q35233222-0BC8A62A-0994-464F-9749-3A1F8BCEFB2A

P304

Q35233222-B05D0232-EF62-4E61-B860-0FE6D8A2DF49

P31

Q35233222-51B98D1C-399D-419E-A9E1-955FC982A1E9

P356

Q35233222-070FCA68-920E-475F-9038-5FDC12432EEE

P478

Q35233222-99D69A61-8F19-41AA-8930-4C2CC79F94EF

P577

Q35233222-56C173E6-F234-434B-A4E2-B72D0FE3FA83

P5875

Q35233222-8C66AC13-2D2B-44A0-91BB-91AA3FA5F8B5

P6179

Q35233222-CD993D4D-E6E9-4282-90F3-65D8DA2C479C

P698

Q35233222-EFB1B7EF-3D9B-46FD-839E-15DA6BC7D900

P932

Q35233222-22912321-D427-423A-A867-8A18DFC2990C

P356

S12906-015-0566-Y

P1433

BMC Complementary and Alternative Medicine

P1476

(5R)-5-Hydroxytriptolide (LLDT ...... KL/RANK/OPG signaling pathway.

@en

P2093

Dongyi He

http://www.w3.org/2001/XMLSchema#string

Jianping Zuo

http://www.w3.org/2001/XMLSchema#string

Mengru Guo

http://www.w3.org/2001/XMLSchema#string

Rongsheng Wang

http://www.w3.org/2001/XMLSchema#string

Shijun He

http://www.w3.org/2001/XMLSchema#string

Ting Jiang

http://www.w3.org/2001/XMLSchema#string

Yi Shen

http://www.w3.org/2001/XMLSchema#string

P2860

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

M-CSF potently augments RANKL-induced resorption activation in mature human osteoclasts

P38 mitogen-activated protein kinase inhibitor, FR167653, inhibits parathyroid hormone related protein-induced osteoclastogenesis and bone resorption.

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Effects of Inositol 1,4,5-triphosphate on Osteoclast Differentiation in RANKL-induced Osteoclastogenesis

Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation.

IL-10 suppresses calcium-mediated costimulation of receptor activator NF-kappa B signaling during human osteoclast differentiation by inhibiting TREM-2 expression.

NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis.

Curcumin as a potential treatment for Alzheimer's disease: a study of the effects of curcumin on hippocampal expression of glial fibrillary acidic protein.

[Progress in research on triptolide].

P2888

s12906-015-0566-y

P304

77

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12906-015-0566-Y

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277579280

http://www.w3.org/2001/XMLSchema#string

P6179

1039375370

http://www.w3.org/2001/XMLSchema#string

P698

25887296

http://www.w3.org/2001/XMLSchema#string

P932

4379732

http://www.w3.org/2001/XMLSchema#string